Hill-Rom Reports Second Quarter Financi...($1044 $895 $946 Rental re...),Health
Home
Biology
Medicine
Technology
Products
News
Definition
Dictionary
Movies
Links
Tags
Search
RSS
Navigation Links
Biology News
Medicine News
Biology Products
Medicine Products
Biology Definition
Medicine Definition
Biology Technology
Medicine Technology
Biology Dictionary
Medicine Dictionary
HOME
>>
MEDICINE
>>
NEWS
Hill-Rom Reports Second Quarter Financial Results
$1044 $895 $946 Rental revenues 464 470 477 --- --- --- Total revenues 1508 1365 1423 YoY % Change 11.1% -9.5% -5.6% Capital sales gross margin %
http://www.bio-medicine.org/inc/biomed/medicine-news.asp
http://feeds.bio-medicine.org/latest-medical-news
Date:5/4/2009
$1,044 $895 $946 Rental revenues 464 470 477 --- --- --- Total revenues 1,508 1,365 1,423 YoY % Change 11.1% -9.5% -5.6% Capital sales gross margin % 40.7% 39.0% 40.0% Rental revenues gross margin % 52.6% 54.3% 55.0% Total gross margin % 44.4% 44.2% 45.1% Other operating expenses 544 518 527 Special charges and other items (see below) 23 492 492 Operating Profit (Loss) 103 (406) (377) Other income / (expense) (11) (8) (8) --- -- -- Income (Loss) from Continuing Operations before Income Taxes 92 (414) (385) Income (Loss) from Continuing Operations - GAAP (1) $67 $(433) $(414) Impairment of goodwill and other intangibles (2) - 470 470 Liko acquisition inventory step-up - 2 2 Liko acquisition integration charges - 1 1 Special charges (3) 14 13 13 Stock modification charge 4 - - Loss on extinguishment of debt 2 - - Separation costs 1 - - --- --- --- Income from Continuing Operations - Adjusted (4) $88 $53 $72
'/>"/>
SOURCE Hill-Rom Holdings, Inc.
Copyright©2009
PR Newswire.
All rights reserved
0
GOOD
Page:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Related medicine news :
1
.
Hill-Rom to Present at the Bank of America 2009 Health Care Conference
2
.
Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Second Quarter Earnings Webcast
3
.
JCR and Hill-Rom Name First Nurse Scholar-in-Residence
4
.
Hill-Rom Announces Second Quarter 2009 Dividend
5
.
Hill-Rom to Present at the Canaccord Adams Musculoskeletal Conference
6
.
Hill-Rom Reports First Quarter Revenue Growth of 3.0 Percent to $352 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.23, an Increase of 15.0 Percent From the Prior Year
7
.
DRE Medical Equipment Now Sells Reconditioned Hill-Rom Hospital Beds
8
.
Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 First Quarter Earnings Webcast
9
.
Hill-Rom Reports First Quarter Revenue of $350 Million and Announces Further Actions to Address Challenging Economic Environment
10
.
JCR, Hill-Rom Launch Nurse Safety Scholar-in-Residence Program
11
.
Hill-Rom Announces First Quarter 2009 Dividend
Post Your Comments:
*
Name:
*
Comment:
*
Email:
Breaking Medicine News(10 mins):
Health News:AdCare Health Systems Completes Private Placement to Fund Aggressive Growth Initiatives 2
Health News:AdCare Health Systems Completes Private Placement to Fund Aggressive Growth Initiatives 3
Health News:Rachel Alexandra, Kendall-Jackson Donate $20,000 to V Foundation for Cancer Research 2
Health News:Vitamin D Linked to Survival in Lymphoma Patients 2
Health News:States Slash Funding for Tobacco Prevention Programs 2
Health News:States Slash Funding for Tobacco Prevention Programs 3
Health News:Genetic Test May Someday Help Spot Breast Cancer 2
Health News:Genetic Test May Someday Help Spot Breast Cancer 3
[
1
] AdCare Health Systems Completes Private Placement to Fund Aggressive Growth Initiatives
[
0
] Rachel Alexandra, Kendall-Jackson Donate $20,000 to V Foundation for Cancer Research
[
0
] Vitamin D Linked to Survival in Lymphoma Patients
[
0
] States Slash Funding for Tobacco Prevention Programs
[
0
] Genetic Test May Someday Help Spot Breast Cancer
Other Medicine News:
Health News:Guardian Survey: More Than Half of Small Business Employers Who Offer Benefits Encounter Challenges During Open Enrollment Season 2
Health News:Guardian Survey: More Than Half of Small Business Employers Who Offer Benefits Encounter Challenges During Open Enrollment Season 3
Health News:Guardian Survey: More Than Half of Small Business Employers Who Offer Benefits Encounter Challenges During Open Enrollment Season 4
Health News:Scientists identify new gene responsible for puberty disorders 2
Health News:Glutamate: Too much of a good thing in schizophrenia? 2
Health News:Eating whole grains lowers heart failure risk, according to new study 2
Health News:Healing process found to backfire in lung patients 2
Guardian Survey: More Than Half of Small Business Employers Who Offer Benefits Encounter Challenges During Open Enrollment Season
Scientists identify new gene responsible for puberty disorders
Glutamate: Too much of a good thing in schizophrenia?
Eating whole grains lowers heart failure risk, according to new study
Rheumatoid Arthritis Rising Among U.S. Women
Healing process found to backfire in lung patients
Breaking Medicine Technology:
ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 2
ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 3
Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2
Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3
Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2
Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3
Garnet Health A Leader in the Healthcare Industry Expands its Operations 51860 1
Garnet Health A Leader in the Healthcare Industry Expands its Operations 51860 2
Garnet Health A Leader in the Healthcare Industry Expands its Operations 51860 3
Dr David Williams Featured on Searchbloodsugar com 51859 1
Dr David Williams Featured on Searchbloodsugar com 51859 2
California Expert Panel Concludes Bisphenol A is Not a Reproductive or Developmental Toxicant 51857 1
California Expert Panel Concludes Bisphenol A is Not a Reproductive or Developmental Toxicant 51857 2
[
0
] ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference
[
0
] Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
[
0
] Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix
Other Medicine Technology:
Innocoll Announces Dosing of Last Patient in US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Cardiac Surgery Patients 2
Innocoll Announces Dosing of Last Patient in US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Cardiac Surgery Patients 3
YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY 2
YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY 3
YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY 4
YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY 5
Innocoll Announces Dosing of Last Patient in US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Cardiac Surgery Patients
YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
Medicine Products:
IgA (sample dilution, 1-shot only) (Liquid)
Urinary Protein (Liquid)
CO
2
(TOTAL)
CRP (Complete Kit with Glass slides)
Biology Navigation
AIDS/HIV
Bioinformatics
Biotechnology
Biochemistry
Cancer
Cell Biology
Developmental Biology
Ecology
Environment
Evolution
Food Technology
Gene
Genetics
Genomics
Health/Medicine
Immunology
Microarray
Microbiology
Molecular
Marine Biology
Nanobiotechnology
Neurobiology
Plant Sciences
Stem Cell
Systems Biology
Virus
Women Health
Medical Navigation
Abortion
Aches
ADHD
Addiction
Alcohol
Allergy
Alternative Medicine
Alzheimer's Dementia
Anxiety/Stress
Arthritis
Autism
Bacteria
Blood
Bird Flu/Avian Flu
Bones
Breast Cancer
Cancer
Cardiovascular
Cervical Cancer
Chikungunya
Cholesterol
Clinical Trials
Colorectal Cancer
Conferences
Crohn's
Cystic Fibrosis
Dengue
Dentistry
Depression
Diabetes
Drug
Eating Disorders
Education
Epilepsy
Erectile Dysfunction
Eye Health/Blindness
Fertility
Flu/Cold
GastroIntestinal
Genetics
Gout
Headache/Migraine
Hearing/Deafness
HIV/AIDS
Huntington's Disease
Hypertension
Immune System/Vaccines
Insurance
Infectious Diseases
Irritable-Bowel Syndrome
Internet
Leukemia
Lifestyle
Liver Disease/Hepatitis
Lung Cancer
Lupus
Mad Cow Disease
Medical Devices
Medical Students/Training
Medicare/Medicaid
Medico
Men's health
Mental Health
MRI/Ultrasound
MRSA/Drug Resistance
Multiple Sclerosis
Muscular Dystrophy
Neurology
Nursing
Nutrition/Diet
Obesity/Weight Loss
Pain/Anesthetics
Parkinson's Disease
Pediatrics/Children's Health
Pharma/Biotech Industry
Pharmacy/Pharmacists
Pregnancy
Premature
Prostate
Psychology/Psychiatry
Rehabilitation
Respiratory/Asthma
SARS
Schizophrenia
Seniors/Aging
Sexual Health
Sleep/Sleep Disorders
Smoking
Statins
Stem Cell Research
Stroke
Surgery
Transplants/Organ Donations
Viruses
Water - Air Quality
Women's Health